Tandem Diabetes Care (TNDM) Current Leases (2019 - 2026)

Tandem Diabetes Care (TNDM) has reported Current Leases for 8 consecutive years, with $20.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Leases rose 1.9% year-over-year to $20.3 million; the trailing twelve-month figure through Jun 2026 stood at $20.3 million (up 1.9% YoY), and the FY2025 full-year result was $19.5 million, up 6.94% from the prior year.
• Current Leases advanced to $20.3 million in Q2 2026 per TNDM's latest filing, from $20.1 million in the prior quarter.
• Across five years, Current Leases topped out at $21.3 million in Q3 2025 and bottomed at $8.1 million in Q1 2022.
• Historically, Current Leases has averaged $16.9 million across 5 years, with a median of $17.8 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Current Leases retreated 14.46% in 2022, then surged 96.15% in 2023.
• Over 5 years, Current Leases stood at $13.1 million in 2022, then jumped by 30.02% to $17.1 million in 2023, then increased by 6.73% to $18.2 million in 2024, then advanced by 6.94% to $19.5 million in 2025, then increased by 4.07% to $20.3 million in 2026.
• According to Business Quant data, Current Leases over the past three periods registered $20.3 million, $20.1 million, and $19.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.